ISRCTN15262355已完成未知
A prospective, placebo controlled, double-blind randomised cross over study evaluating the effects of xylitol-containing chewing gum versus ordinary chewing gum on recurrent purulent upper respiratory tract infections
Department of Health (UK)0 个研究点目标入组 30 人开始时间: 2003年9月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •30 patients aged between 5-65.
排除标准
- •Does not match inlcusion criteria
研究者
相似试验
进行中（未招募）
1 期
Clinical trial to assess the safety and efficacy of IFB-088 plus riluzole 100 mg vs placebo plus riluzole 100 mg in patients with bulbar-onset amyotrophic lateral sclerosisEUCTR2021-003875-32-ITInFlectis BioScience50
进行中（未招募）
不适用
A double-blind, randomized, placebo-controlled, repeat dose study to compare the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK189075 with GW869682 in subjects with type 2 diabetes mellitusEUCTR2005-002978-30-DEGlaxoSmithKlin Research and Development Ltd45
进行中（未招募）
1 期
A Double Blind, Placebo- and Active-Controlled, Randomized, Sequential Group, Multiple Dose Study to Examine the Effect of the CRF1-Receptor Antagonist R317573 on 7.5% CO2-Inhalation Induced Anxiety in Healthy Subjects - Not availableEUCTR2006-003659-19-GBJanssen-Cilag International N.V.32
终止
2 期
Safety and efficacy of stem cell treatment for chronic migraine headacheACTRN12615001260516Cell-Innovations4
进行中（未招募）
不适用
A study to see if multiple doses of REGN668 given by injections under the skin is effective, safe and how it acts in the body of adult patients with moderate-to-severe atopic dermatitis caused by allergic response.MedDRA version: 15.0Level: LLTClassification code 10003639Term: Atopic dermatitisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersAtopic DermatitisEUCTR2011-003836-29-DERegeneron Pharmaceuticals, Inc.100